{"id":965537,"date":"2026-05-20T18:59:21","date_gmt":"2026-05-20T22:59:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/"},"modified":"2026-05-20T18:59:21","modified_gmt":"2026-05-20T22:59:21","slug":"cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/","title":{"rendered":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, May  20, 2026  (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.<\/p>\n<p align=\"left\">The notice of meeting is available on the Cellectis website:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hj9hMQEBksutEg_3kdSbjzy-NzYUceiOVsRvXkyQ4Zy8dDgI8t4Vcq1Mdw7PvvZa6Wwa_i1ZHLazeD8zQJDFf75mpiGAOGQcBA8lrhJOdDdfqupjtE1bSOtCTO23CJAPG8tPVbpEWeXrx5KA0lE1KST3fJptiYKBahziQ6TafhNEk2gmoEMvXe3tTtwnvcT3\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/<\/a><\/p>\n<p align=\"justify\">\n        <strong>About\u202fCellectis<\/strong>\u202f\u202f\u202f\u202f\u202f<br \/>Cellectis\u202fis a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company\u202futilizes\u202fan allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and\u202fready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities,\u202fCellectis\u202fis one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish.\u202f\u202f\u202f\u202f\u202f<br \/>\u202f\u202f\u202f\u202f<br \/>Cellectis\u2019 headquarters are in Paris, France, with locations in New York and Raleigh, NC.\u202fCellectis\u202fis listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). <br \/>To find out more, visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l4bvuh5aIWuL8vEX46UAzAWo46aOYHJFbAv7aHZk2eAeFtYWLVySaT8YzTAljn0xEgsDK5Y0RBsakWe27ShWy5eJasY4Huyhj_Tb0VrNZek=\" rel=\"nofollow\" target=\"_blank\">www.cellectis.com<\/a>\u202fand follow\u202fCellectis\u202fon\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O-drREOzm3u8kE-T_oxOpVvJgDu641-8VLZ2P9TWHMNErxuUbTF0BOoiYW9PqQ5ZnlFk1d1dB1CX8LUgTGfQK42xFJS5o7dGhSbT3EOnUanXrLFyX97wlmTx8Fs8yrxT\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u202fand\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y2XqZtXm5DsteqVtOo7Qb4xNNzGoopq6xJ3IPz0rSLOa9_SueHyyhuSGFWM_IYjxHMLrnWqk0udENFi5A0_7rA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.\u202f\u202f<\/p>\n<p align=\"justify\">\n        <strong>For further information on\u202fCellectis, please contact:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>\u202f\u202f\u202f\u202f\u202f<br \/><strong>Media contacts:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zOYwBXFeoaZEDhKkyP1tGbQS7J1rkptnAEEynMkqImRjfQoT0YG38ba35zcKFYF_BngG7Jma3pWgfAskidTf-rFC37lR3N8mwi60AHdoTgE=\" rel=\"nofollow\" target=\"_blank\">media@cellectis.com<\/a><br \/>Patricia Sosa Navarro, Chief of Staff to the CEO,\u202f+33 (0)7 76 77 46 93\u202f\u202f\u202f\u202f\u202f\u202f<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations contact:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>Arthur Stril, Chief Financial Officer &amp; Chief Business Officer,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BuQ-BMpnIjqXNE0WtiWranz4fK4x-Fr9bjr0J22Ju78_66mVRyFjJrNyh9YJ00SKc56j3ZJvcEMZnO3_OJzW5-8a0fpmLzlxl8lMdurEri8=\" rel=\"nofollow\" target=\"_blank\">investors@cellectis.com<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a href=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/237f5979-2016-4b99-909a-a37de1d30ac6\" rel=\"nofollow\" target=\"_blank\">Shareholder&#8217;s meeting announcement PR_ENGLISH.pdf<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGQzZTNkODYtZGUxOS00YTI2LTk0ZmQtY2I4ZWUwNTk0OTEwLTEwNjE0NDgtMjAyNi0wNS0yMC1lbg==\/tiny\/Cellectis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice of meeting is available on the Cellectis website:\u00a0https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About\u202fCellectis\u202f\u202f\u202f\u202f\u202fCellectis\u202fis a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company\u202futilizes\u202fan allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and\u202fready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-965537","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice of meeting is available on the Cellectis website:\u00a0https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About\u202fCellectis\u202f\u202f\u202f\u202f\u202fCellectis\u202fis a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company\u202futilizes\u202fan allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and\u202fready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in &hellip; Continue reading &quot;Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-20T22:59:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026\",\"datePublished\":\"2026-05-20T22:59:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/\",\"name\":\"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\",\"datePublished\":\"2026-05-20T22:59:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/","og_locale":"en_US","og_type":"article","og_title":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk","og_description":"NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice of meeting is available on the Cellectis website:\u00a0https:\/\/www.cellectis.com\/en\/investors\/general-meetings\/ About\u202fCellectis\u202f\u202f\u202f\u202f\u202fCellectis\u202fis a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company\u202futilizes\u202fan allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and\u202fready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in &hellip; Continue reading \"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-20T22:59:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026","datePublished":"2026-05-20T22:59:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/","name":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=","datePublished":"2026-05-20T22:59:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzg5NiM3NjEzMjU1IzIwNDk4Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cellectis\u2019 Annual Shareholders General Meeting to be Held on June 25, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=965537"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=965537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=965537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=965537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}